Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds-Reference-Cited by-同舟云学术

Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds

Published:2013-08 Issue:15 Volume:21 Page:4600-4613
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Ishichi Yuji,Kimura Eiji,Honda Eiji,Yoshikawa Masato,Nakahata Takashi,Terao Yasuko,Suzuki Atsuko,Kawai Takayuki,Arakawa Yuuichi,Ohta Hiroyuki,Kanzaki Naoyuki,Nakagawa Hideyuki,Terauchi Jun

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. World Health Organization (WHO). Fact sheet No. 369: Depression, October, 2012. http://www.who.int/mediacentre/factsheets/fs369/en/index.html.

2. Current investigational drugs for major depression

3. Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited

4. Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity

5. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressant Drug Discovery and Development: Mechanism and Drug Design Based on Small Molecules;Advanced Therapeutics;2022-03-30

2. Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges;Journal of Medicinal Chemistry;2017-07-21

3. Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors—Part 2;Bioorganic & Medicinal Chemistry;2016-07

4. Preparation of (S)-4-(1-(3,4-dichlorophenyl)-2-methoxyethyl)piperidine;Tetrahedron: Asymmetry;2015-09

5. Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor;Bioorganic & Medicinal Chemistry;2015-08